105 related articles for article (PubMed ID: 29941397)
1. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
Wang X; Chen D; Chen B
Acad Radiol; 2020 Dec; 27(12):1720-1726. PubMed ID: 29941397
[TBL] [Abstract][Full Text] [Related]
2. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Woo HG; Wang XW; Budhu A; Kim YH; Kwon SM; Tang ZY; Sun Z; Harris CC; Thorgeirsson SS
Gastroenterology; 2011 Mar; 140(3):1063-70. PubMed ID: 21094160
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
4. Depicting the role of TP53 in hepatocellular carcinoma progression.
Villanueva A; Hoshida Y
J Hepatol; 2011 Sep; 55(3):724-725. PubMed ID: 21616106
[TBL] [Abstract][Full Text] [Related]
5. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of the
Yu X; Mao SQ; Shan YY; Huang Y; Wu SD; Lu CD
Genet Test Mol Biomarkers; 2022 Oct; 26(10):476-484. PubMed ID: 36264169
[No Abstract] [Full Text] [Related]
7. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
8. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma.
Long J; Wang A; Bai Y; Lin J; Yang X; Wang D; Yang X; Jiang Y; Zhao H
EBioMedicine; 2019 Apr; 42():363-374. PubMed ID: 30885723
[TBL] [Abstract][Full Text] [Related]
10. TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.
Shen T; Li SF; Wang JL; Zhang T; Zhang S; Chen HT; Xiao QY; Ren WH; Liu C; Peng B; Ji XN; Yang Y; Lu PX; Chen TY; Yu L; Ji Y; Jiang DK
Liver Int; 2020 Nov; 40(11):2834-2847. PubMed ID: 32594568
[TBL] [Abstract][Full Text] [Related]
11. TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma.
Zhao Y; Zhu C; Chang Q; Yang J; Liu Y; Peng P; Liu C; Cheng R; Chen X; Wu Y; Cheng L; Hu L; Wu X; Yin J
Biomark Med; 2021 Jun; 15(9):615-622. PubMed ID: 34037458
[No Abstract] [Full Text] [Related]
12. Evaluation of TP53/PIK3CA mutations using texture and morphology analysis on breast MRI.
Moon WK; Chen HH; Shin SU; Han W; Chang RF
Magn Reson Imaging; 2019 Nov; 63():60-69. PubMed ID: 31425802
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
[TBL] [Abstract][Full Text] [Related]
14. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
16. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
Molleví DG; Serrano T; Ginestà MM; Valls J; Torras J; Navarro M; Ramos E; Germà JR; Jaurrieta E; Moreno V; Figueras J; Capellà G; Villanueva A
Carcinogenesis; 2007 Jun; 28(6):1241-6. PubMed ID: 17259658
[TBL] [Abstract][Full Text] [Related]
17. Correlations between P53 Mutation Status and Texture Features of CT Images for Hepatocellular Carcinoma.
Wu H; Chen X; Chen J; Luo Y; Jiang X; Wei X; Tang W; Liu Y; Liang Y; Liu W; Guo Y
Methods Inf Med; 2019 Jun; 58(1):42-49. PubMed ID: 31163452
[TBL] [Abstract][Full Text] [Related]
18. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
[TBL] [Abstract][Full Text] [Related]
19. Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Long J; Wang Y; Li M; Tong WM; Jia JD; Huang J
Oncol Rep; 2013 Jul; 30(1):119-24. PubMed ID: 23624687
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]